Healthcare (SH:603313) Shang Hai Zheng Quan Bao·2025-07-31 18:03Group 1 - The company has approved a share repurchase plan to buy back shares worth between RMB 0.85 billion and RMB 1.70 billion for employee stock ownership plans or equity incentives [1] - The repurchase will be conducted through centralized bidding and will not exceed 150% of the average trading price of the company's shares over the 30 trading days prior to the board's decision [1] - The repurchase period is set for up to 12 months from the board's approval date [1] Group 2 - As of July 31, 2025, the company has repurchased a total of 18.79315 million shares, accounting for 3.29% of the total share capital, with a maximum purchase price of RMB 9.139 per share and a minimum of RMB 8.070 per share [2] - The total amount paid for the repurchased shares is RMB 161.192413 million, excluding transaction fees [2] - The progress of the repurchase aligns with the established share repurchase plan [2] Group 3 - The company will adhere to relevant regulations regarding share repurchase and will make decisions based on market conditions during the repurchase period [3] - The company commits to timely information disclosure regarding the progress of the share repurchase [3]